SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    M. Makatsori, G. W. Scadding, C. Lombardo, G. Bisoffi, E. Ridolo, S. R. Durham, G. Senna, Dropouts in sublingual allergen immunotherapy trials – a systematic review, Allergy, 2014, 69, 5
  2. 2
    Christian Domingo, Omalizumab for Severe Asthma: Efficacy Beyond the Atopic Patient?, Drugs, 2014, 74, 5, 521

    CrossRef

  3. 3
    Giovanni Passalacqua, Carlos E. Baena-Cagnani, Jean Bousquet, Giorgio Walter Canonica, Thomas B. Casale, Linda Cox, Stephen R. Durham, Desiréé Larenas-Linnemann, Dennis Ledford, Ruby Pawankar, Paul Potter, Nelson Rosario, Dana Wallace, Richard F. Lockey, Grading local side effects of sublingual immunotherapy for respiratory allergy: Speaking the same language, Journal of Allergy and Clinical Immunology, 2013, 132, 1, 93

    CrossRef

  4. 4
    C. Mailhol, A. Didier, Immunothérapie allergénique dans le traitement de l’allergie aux pollens, Revue des Maladies Respiratoires, 2013, 30, 2, 142

    CrossRef

  5. 5
    Joaquín Quiralte, José L Justicia, Victoria Cardona, Ignacio Dávila, Estefanía Moreno, Berta Ruiz, Mario A García, Is faster safer? Cluster versus short conventional subcutaneous allergen immunotherapy, Immunotherapy, 2013, 5, 12, 1295

    CrossRef

  6. 6
    William R. Reisacher, Jiovani M. Visaya, Patient adherence to allergy immunotherapy, Current Opinion in Otolaryngology & Head and Neck Surgery, 2013, 21, 3, 256

    CrossRef

  7. 7
    R. Balaji, B.G. Parasuramalu, B.V. Chandregowda, Gangaboraiah, Safety, tolerability and clinical efficacy of ultra-rush sublingual immunotherapy among patients suffering from allergic rhinitis, Allergologia et Immunopathologia, 2013,

    CrossRef

  8. 8
    Giovanni Passalacqua, Valentina Garelli, Francesca Sclifò, Giorgio Walter Canonica, Sublingual immunotherapy for allergic rhinitis and conjunctivitis, Immunotherapy, 2013, 5, 3, 257

    CrossRef

  9. 9
    Antonio Cappella, Stephen R. Durham, Allergen immunotherapy for allergic respiratory diseases, Human vaccines & immunotherapeutics, 2012, 8, 10, 1499

    CrossRef

  10. 10
    Moises A Calderon, Martin Penagos, Aziz Sheikh, Giorgio W Canonica, Stephen Durham, Cochrane Review: Sublingual immunotherapy for treating allergic conjunctivitis, Evidence-Based Child Health: A Cochrane Review Journal, 2012, 7, 3
  11. 11
    Nerin N. Bahceciler, Nilufer Galip, Comparing subcutaneous and sublingual ımmunotherapy, Current Opinion in Allergy and Clinical Immunology, 2012, 12, 6, 640

    CrossRef

  12. 12
    Claire Mailhol, Alain Didier, Specific immunotherapy in grass pollen allergy, Human vaccines & immunotherapeutics, 2012, 8, 10, 1544

    CrossRef

  13. 13
    Takashi Fujimura, Yoshitaka Okamoto, Masaru Taniguchi, Therapeutic Effects and Biomarkers in Sublingual Immunotherapy: A Review, Journal of Allergy, 2012, 2012, 1

    CrossRef

  14. 14
    David I. Bernstein, Michael S. Blaiss, Linda S. Cox, Ira Finegold, Bobby Q. Lanier, Harold S. Nelson, Dana V. Wallace, Current standards and future directions in immunotherapy: perspectives on challenges and opportunities for the allergist, Annals of Allergy, Asthma & Immunology, 2011, 107, 5, 422

    CrossRef

  15. 15
    X. Van der Brempt, J. Cumps, E. Capieaux, Efficacité clinique du 2L®ALERG, un nouveau traitement de type immunomodulateur par voie sublinguale dans le rhume des foins : une étude en double insu contre placebo, Revue Française d'Allergologie, 2011, 51, 4, 430

    CrossRef

  16. 16
    Linda Cox, Dana Wallace, Specific Allergy Immunotherapy for Allergic Rhinitis: Subcutaneous and Sublingual, Immunology and Allergy Clinics of North America, 2011, 31, 3, 561

    CrossRef

  17. 17
    Nerin Nadir Bahceciler, Nazan Cobanoglu, Subcutaneous versus sublingual immunotherapy for allergic rhinitis and/or asthma, Immunotherapy, 2011, 3, 6, 747

    CrossRef

  18. 18
    Sandra Y. Lin, Bryan Leatherman, Sublingual Immunotherapy, Otolaryngologic Clinics of North America, 2011, 44, 3, 753

    CrossRef

  19. 19
    Giovanni Passalacqua, Giorgio Walter Canonica, Sublingual Immunotherapy for Allergic Respiratory Diseases: Efficacy and Safety, Immunology and Allergy Clinics of North America, 2011, 31, 2, 265

    CrossRef

  20. 20
    Giovanni Passalacqua, Enrico Compalati, Giorgio W Canonica, Sublingual immunotherapy for allergic rhinitis: an update, Current Opinion in Otolaryngology & Head and Neck Surgery, 2011, 19, 1, 43

    CrossRef

  21. 21
    Alain Didier, Margitta Worm, Friedrich Horak, Gordon Sussman, Olivier de Beaumont, Martine Le Gall, Michel Melac, Hans-Jorgen Malling, Sustained 3-year efficacy of pre- and coseasonal 5-grass-pollen sublingual immunotherapy tablets in patients with grass pollen–induced rhinoconjunctivitis, Journal of Allergy and Clinical Immunology, 2011, 128, 3, 559

    CrossRef

  22. 22
    S. R. Durham, Sustained effects of grass pollen AIT, Allergy, 2011, 66,
  23. 23
    S. Radulovic, D. Wilson, M. Calderon, S. Durham, Systematic reviews of sublingual immunotherapy (SLIT), Allergy, 2011, 66, 6
  24. 24
    Stephen R. Durham, Waltraud Emminger, Alexander Kapp, Giselda Colombo, Jan G.R. de Monchy, Sabina Rak, Glenis K. Scadding, Jens S. Andersen, Bente Riis, Ronald Dahl, Long-term clinical efficacy in grass pollen–induced rhinoconjunctivitis after treatment with SQ-standardized grass allergy immunotherapy tablet, Journal of Allergy and Clinical Immunology, 2010, 125, 1, 131

    CrossRef

  25. 25
    M. Calderon, R. Mösges, M. Hellmich, P. Demoly, Towards evidence-based medicine in specific grass pollen immunotherapy, Allergy, 2010, 65, 4
  26. 26
    Elina Toskala, A contemporary review of sublingual immunotherapy, The Laryngoscope, 2009, 119, 11
  27. 27
    C. Lombardi, C. Incorvaia, M. Braga, G. Senna, G. W. Canonica, G. Passalacqua, Administration regimens for sublingual immunotherapy to pollen allergens: What do we know?, Allergy, 2009, 64, 6
  28. 28
    &NA;, CHAPTER 4: CLINICAL EFFICACY OF SUBLINGUAL IMMUNOTHERAPY, World Allergy Organization Journal, 2009, 2, 11, 245

    CrossRef

  29. 29
    Gianenrico Senna, Erminia Ridolo, Moises Calderon, Carlo Lombardi, Giorgio W Canonica, Giovanni Passalacqua, Evidence of adherence to allergen-specific immunotherapy, Current Opinion in Allergy and Clinical Immunology, 2009, 9, 6, 544

    CrossRef

  30. 30
    A. Didier, Quel avenir pour l’immunothérapie spécifique dans le traitement de l’allergie pollinique ?, Revue des Maladies Respiratoires, 2009, 26, 6, 693

    CrossRef

  31. 31
    Julia Vent, Walter Lehmacher, The problem of placebo-controlled trials allowing rescue medication: how to assess efficacy in rhinosinusitis and allergic rhinoconjunctivitis when both groups receive active rescue treatment, Current Opinion in Allergy and Clinical Immunology, 2009, 1

    CrossRef

  32. 32
    Suzana Radulovic, Moises A Calderon, Duncan Wilson, Stephen Durham, Sublingual immunotherapy for allergic rhinitis, The Cochrane Library,
  33. 33
    Moises A Calderon, Martin Penagos, Aziz Sheikh, Giorgio W Canonica, Stephen Durham, Sublingual immunotherapy for treating allergic conjunctivitis, The Cochrane Library,